title: Gene-environment interactions in chronic obstructive pulmonary disease.
abstract: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death throughout the world and is largely associated with cigarette smoking. Despite the appreciation of the central role of smoking in the development of COPD, only a relatively small number of smokers (15%-20%) develop COPD. Recent studies depicting familial aggregation suggest that some subjects may have a genetic predisposition to developing COPD. In this respect, a number of single nucleotide polymorphisms have been reported in association with different COPD features (subphenotypes), although much of this data remains controversial. Classical genetic studies (including twin and family studies) assume an "equal-environment" scenario, but as gene-environment interactions occur in COPD, this assumption needs revision. Thus, new integrated models are needed to examine the major environmental factors associated with COPD which include smoking as well as air pollution, and respiratory infections, and not only genetic predisposition. Revisiting this area, may help answer the question of what has more bearing in the pathogenesis of COPD--the environment or the genomic sequence of the affected subjects. It is anticipated that an improved understanding of this interaction will both enable improved identification of individuals susceptible to developing this disease, as well as improved future treatments for this disease.
authors.affiliation: MedImmune, Gaithersburg, MD 20878, USA. molfinon@medimmune.com
authors.forename: Nestor A
authors.initials: NA
authors.lastname: Molfino
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Coyle
mesh_terms: D000397:Air Pollution / Q000009:adverse effects; D004777:Environment; D004781:Environmental Exposure; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008954:Models, Biological; D010641:Phenotype; D029424:Pulmonary Disease, Chronic Obstructive / Q000235:genetics* / Q000503:physiopathology; D018570:Risk Assessment; D012907:Smoking / Q000009:adverse effects